208 related articles for article (PubMed ID: 24674923)
21. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
[TBL] [Abstract][Full Text] [Related]
22. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
Jacobs S; Price Evans DA; Tariq M; Al Omar NF
Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of corticosteroid insufficiency in Thai patients with septic shock.
Ratanarat R; Promsin P; Srivijitkamol A; Leemingsawat C; Permpikul C
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S187-95. PubMed ID: 20364574
[TBL] [Abstract][Full Text] [Related]
24. Counteraction of early circulatory derangement by administration of low dose steroid treatment at the onset of established endotoxemic shock is not directly mediated by TNF-α and IL-6.
Söderberg E; Lipcsey M; Sjölin J; Larsson A; Eriksson MB
Steroids; 2012 Sep; 77(11):1101-6. PubMed ID: 22705410
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of plasma NOx levels in severe sepsis: high interindividual variability and correlation with illness severity, but lack of correlation with cortisol levels.
Ho JT; Chapman MJ; O'Connor S; Lam S; Edwards J; Ludbrook G; Lewis JG; Torpy DJ
Clin Endocrinol (Oxf); 2010 Sep; 73(3):413-20. PubMed ID: 20455885
[TBL] [Abstract][Full Text] [Related]
26. Profile of the risk of death after septic shock in the present era: an epidemiologic study.
Pavon A; Binquet C; Kara F; Martinet O; Ganster F; Navellou JC; Castelain V; Barraud D; Cousson J; Louis G; Perez P; Kuteifan K; Noirot A; Badie J; Mezher C; Lessire H; Quantin C; Abrahamowicz M; Quenot JP;
Crit Care Med; 2013 Nov; 41(11):2600-9. PubMed ID: 23963127
[TBL] [Abstract][Full Text] [Related]
27. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock.
de Jong MF; Beishuizen A; Spijkstra JJ; Groeneveld AB
Crit Care Med; 2007 Aug; 35(8):1896-903. PubMed ID: 17568326
[TBL] [Abstract][Full Text] [Related]
28. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
Miller JT; Welage LS; Kraft MD; Alaniz C
J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
[TBL] [Abstract][Full Text] [Related]
29. [Cortisol in critically ill patients with sepsis: physiologic functions and therapeutic implications].
Briegel J
Wien Klin Wochenschr; 2000 Apr; 112(8):341-52. PubMed ID: 10849939
[TBL] [Abstract][Full Text] [Related]
30. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit.
Pène F; Percheron S; Lemiale V; Viallon V; Claessens YE; Marqué S; Charpentier J; Angus DC; Cariou A; Chiche JD; Mira JP
Crit Care Med; 2008 Mar; 36(3):690-6. PubMed ID: 18431262
[TBL] [Abstract][Full Text] [Related]
31. Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.
Oh M; Patanwala AE; Alkhatib N; Almutairi A; Abraham I; Erstad B
Crit Care Med; 2020 Oct; 48(10):e906-e911. PubMed ID: 32701552
[TBL] [Abstract][Full Text] [Related]
32. Reversal of late septic shock with supraphysiologic doses of hydrocortisone.
Bollaert PE; Charpentier C; Levy B; Debouverie M; Audibert G; Larcan A
Crit Care Med; 1998 Apr; 26(4):645-50. PubMed ID: 9559600
[TBL] [Abstract][Full Text] [Related]
33. Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study.
Coloretti I; Biagioni E; Venturelli S; Munari E; Tosi M; Roat E; Brugioni L; Gelmini R; Venturelli C; Girardis M
J Crit Care; 2020 Oct; 59():37-41. PubMed ID: 32512351
[TBL] [Abstract][Full Text] [Related]
34. Before-after study of a standardized hospital order set for the management of septic shock.
Micek ST; Roubinian N; Heuring T; Bode M; Williams J; Harrison C; Murphy T; Prentice D; Ruoff BE; Kollef MH
Crit Care Med; 2006 Nov; 34(11):2707-13. PubMed ID: 16943733
[TBL] [Abstract][Full Text] [Related]
35. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
[TBL] [Abstract][Full Text] [Related]
36. Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis plan.
Fujii T; Udy AA; Deane AM; Luethi N; Bailey M; Eastwood GM; Frei D; French C; Orford N; Shehabi Y; Young PJ; Bellomo R;
Crit Care Resusc; 2019 Jun; 21(2):119-125. PubMed ID: 31142242
[TBL] [Abstract][Full Text] [Related]
37. [Cortisol in critically ill patients with sepsis--physiological functions and therapeutic implications].
Briegel J
Wien Klin Wochenschr; 2002; 114 Suppl 1():9-19. PubMed ID: 15503552
[TBL] [Abstract][Full Text] [Related]
38. [Septic shock in intensive care units. Current focus on treatment].
Arriagada S D; Donoso F A; Cruces R P; Díaz R F
Rev Chil Pediatr; 2015; 86(4):224-35. PubMed ID: 26323988
[TBL] [Abstract][Full Text] [Related]
39. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial.
Loisa P; Parviainen I; Tenhunen J; Hovilehto S; Ruokonen E
Crit Care; 2007; 11(1):R21. PubMed ID: 17306016
[TBL] [Abstract][Full Text] [Related]
40. Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5'-triphosphate synthase activity.
Japiassú AM; Santiago AP; d'Avila JC; Garcia-Souza LF; Galina A; Castro Faria-Neto HC; Bozza FA; Oliveira MF
Crit Care Med; 2011 May; 39(5):1056-63. PubMed ID: 21336129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
